Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check it out...because I invested in VATE at the low and made 250% I can afford more NXTTF and GRWG since they're still looking for a bottom. This is about investing right??
What Is Hemp? Understanding The Differences Between Hemp and Cannabis
by Matt Price
When trying to wrap your head around the differences between hemp and cannabis, it is important to begin with this simple concept: Both hemp and cannabis ultimately come from the same plant… just different parts. Whether you call something hemp or cannabis will depend on a variety of factors which we will explore in this article. However, despite the fact that the terms hemp and cannabis are often used interchangeably, they do have separate connotations.
Differentiating Between Hemp and Cannabis Unfortunately, prohibition has spurred a lack of education surrounding the cannabis plant. This has led to countless rumors about what makes hemp different from cannabis. Everything from “hemp plants are male and cannabis plants are female” to “cannabis is a drug and the other is not” are incorrectly being preached as common knowledge to unknowing bystanders. So, how are these terms supposed to be used? Let’s find out.
“Health Canada defines hemp as products of Cannabis Sativa which contain less than 0.3 percent THC, whereas US law defines hemp as all parts of any Cannabis Sativa plant containing no psychoactive properties, except for defined exceptions.”
According to a 1976 study published by the International Association of Plant Taxonomy concluded “both hemp varieties and marijuana varieties are of the same genus, Cannabis, and the same species, Cannabis Sativa. Further, there are countless varieties that fall into further classifications within the species Cannabis Sativa.”
However, depending on how theplant is grown and utilized will determine which term is correct. For instance, the term cannabis (or marijuana) is used when describing a Cannabis Sativa plant that is bred for its potent, resinous glands (known as trichomes). These trichomes contain high amounts of tetrahydrocannabinol (THC), the cannabinoid most known for its psychoactive properties.
hempHemp, on the other hand, is used to describe a Cannabis Sativa plant that contains only trace amounts of THC. Hemp is a high-growing plant, typically bred for industrial uses such as oils and topical ointments, as well as fiber for clothing, construction, and much more.
Only products made from industrial hemp (less than 0.3% THC) are legal to sell, buy, consume, and ship. This single factor (0.3%) is how most people distinguish between what is classified as “hemp” and what is classified as “cannabis.” This limit has led to mass controversy (for good reason), which we will dive into a bit later. But first, let’s take a look at how hemp is utilized all over the world.
Industrial Hemp Uses From hemp apparel and accessories to diets and hempseed oil cosmetics, the plant is seemingly found everywhere you look. Hemp can be made into wax, resin, rope, cloth paper and fuel, among many other things.
hemp uses
Hemp for Paper One of the reasons hemp is so valuable is because of its fiber length and strength. These long bast fibers have been used to make paper almost for 2 millennia. Thomas Jefferson drafted both the Declaration of Independence and the U.S. Constitution on hemp paper.
hemp paperUntil the early 19th century, hemp and flax were the two chief paper-making materials. In historical times, paper was processed from hemp rag. Using hemp directly for paper was considered too expensive, due to its lack of demand at the time. Wood-based paper came into use when mechanical and chemical pulping was developed in the mid 1800s in Germany and England. Today, at least 95% of paper is made from wood pulp. This makes little sense when considering hemp can easily produce much more paper per acre than wood pulp alternatives.
The hemp paper process also utilizes less energy and fewer chemicals than tree paper processing and doesn’t create the harmful dioxins, chloroform, or any of the other 2,000 chlorinated organic compounds that have been identified as byproducts of the wood paper process.
According to Hemp: A New Crop with New Uses for North America, “the primary bast fibers in the bark are 5–40 mm long, and are amalgamated in fiber bundles which can be 1–5 m long (secondary bast fibers are about 2 mm long). The woody core fibers are short—about 0.55 mm—and like hardwood fibers are cemented together with considerable lignin. The core fibers are generally considered too short for high grade paper applications (a length of 3 mm is considered ideal), and too much lignin is present.”
Hemp for Food Studies have shown consumption of raw hemp seeds can help lower blood pressure and cholesterol, accelerate weight loss, improve one’s immune system, control blood sugar levels, and even reduce inflammation. This makes hemp seeds extremely nutritious. They contain a bundle of essential amino acids and fatty-acids. This may explain why the “hemp for food” industry is growing rapidly and has increased over 300 percent, to an estimated 25,000 products, in the past few years.
hemp oilIn its raw form, hemp has the second highest amount of protein of any food (soy being the highest). However, because the hemp seed’s protein more closely resembles the protein found in human blood, it is much easier to digest than soy protein. Hemp seeds can be eaten whole, pressed into oil, or ground into flour for baking.
In America, products derived from hemp seed, such as hemp seed spreads, hemp seed energy bars, hemp seed meal, and hemp oil – are widely available in natural food stores such as Whole Foods or Trader Joe’s supermarkets.
Hemp for Health & Body Hemp seed oil is perfectly suited for hair and skin care. Its nutritional value, combined with its moisturizing and replenishing EFA’s, make it one of the best vegetable body care foundations. Hemp seed oil’s EFA complement includes polyunsaturated fatty acids, omega-3, omega-6, omega-9, linoleic acid, and gamma linoleic acids (GLA’s). Although they are very effective in skin care maintenance, GLA’s are rarely found in natural oils. Hemp is an excellent source of GLA’s.
Additionally, oil derived from hemp seed has shown promise in treating eczema (chronic dry skin) in patients, although whole-plant cannabis oil has been proven to be more effective in treating more severe skin disorders, like skin cancer.
Hemp for Fuel Hemp seeds have provided a combustible fuel oil throughout human history. Basically, hemp can provide two types of fuel:
1. Hemp biodiesel – made from the oil of the (pressed) hemp seed. 2. Hemp ethanol/methanol – made from the fermented stalk.
The concept of using oil derived from vegetables as an engine fuel is nothing new. In 1895, Dr. Rudolf Diesel developed the first diesel engine to run on vegetable oil — peanut oil to be exact. When you press the hemp seeds and extract the oil, you are actually creating hemp biodiesel. Additionally, through processes such as gasification, hemp can be used to make both ethanol and methanol.
The Controversy of Classifying Hemp vs. Cannabis The international definition of hemp (as opposed to cannabis) was developed by a Canadian researcher in 1971 who goes by the name of Ernest Small. Small’s arbitrary 0.3 percent THC limit has become standard around the world as the official limit for legal hemp, after he published a little-known, but very influential book titled The Species Problem in Cannabis.
“There is not any natural point at which the cannabinoid content can be used to distinguish strains of hemp and marijuana.” – Ernest Small
In this same book, Small discusses how “there is not any natural point at which the cannabinoid content can be used to distinguish strains of hemp and marijuana.” Despite this, Small continued to “draw an arbitrary line on the continuum of cannabis types, and decided that 0.3 percent THC in a sifted batch of cannabis flowers was the difference between hemp and marijuana.” As you can imagine, this has led to some controversy and confusion as to what truly constitutes the difference between hemp and cannabis.
Additionally, your location will determine your understanding of what constitutes hemp vs cannabis. For instance, Health Canada defines hemp as products of Cannabis Sativa which contain less than 0.3 percent THC, whereas U.S. law defines hemp as all parts of any Cannabis Sativa plant containing no psychoactive properties, except for defined exceptions.
A recent court case between Hemp Industries Association v. DEA concluded “the DEA can regulate foodstuffs containing natural THC if it is contained within marijuana, and can regulate synthetic THC of any kind. But they cannot regulate naturally-occurring THC not contained within or derived from marijuana—i.e., non-psychoactive hemp products— because non-psychoactive hemp is not included in Schedule I.”
Hemp Seed Oil vs. Hemp Extract vs. Cannabis Oil Hemp seed oil is extracted by pressing the seeds of the female cannabis hemp plant. The hemp oil extracted is very nutritious in terms of a dietary supplement but hemp seed oil lacks cannabinoids, which are the main compounds found in the cannabis plant that have the ability to help battle cancer. Hemp seed oil is found mostly in products in your local grocery store and typically contains twice the levels of omega 3 found in olive oil with only half of the total calories.
There is a big difference between hemp seed oil and hemp/CBD extract. Hemp/CBD extract is the main ingredient in popular products like Charlotte’s Web and other CBD-specific brands. Products containing hemp/CBD extract do have a wide range of cannabinoids, just limited to no THC. Because the total THC content is below the legal limit, products consisting of hemp/CBD extract can be shipped nationwide, across all 50 states. These types of products can be beneficial for increasing the quality of one’s life; many patients report that they have found relief for a wide range of ailments from hemp extract alone. However, the lack of THC does provide an issue for patients that have a treatment plan that requires high doses of THC, so it will depend on your specific use-case.
Patients looking to treat more serious diseases and chronic illnesses will want to look into whole-plant cannabis oil treatments (i.e., Rick Simpson Oil). Products consisting of whole plant cannabis oil provide high doses of concentrated cannabinoids (e.g., THC, CBD, CBN, CBG, etc…), terpenes, and other compounds from the plant that many patients and caregivers need to help find relief from a wide variety of ailments.
Click here to learn more about different types of cannabis extracts
Hahahaha...man you gotta tell me more about why you hate hemp so much as an investment. Is it because hemp is the fastest growing plant and therefore to plentiful to be profitable? Did you get burned?? What's up?
Hey thanks! Looking good, it passed bigly! Now on to the committee, I don't know anything about the Canadian process or how much more/less difficult it will be to pass the committee but it seems promising that Canadian stocks resurge tomorrow.
Lol...all that hate...hate is an emotion. it's uselass...even hurtful. I thought emotions and trading didn't mix. I'm gonna load the NTXXF dip when it's going back up. I like going up. It sure keeps dipping. US is dominating until Canada decides to vote. At least that's how I'm seeing it.
Jeff Thomas Admin · Yesterday at 2:46am From Chris Mitchell
Friday March 16th myself and a handful of investment professionals are meeting with Martin Cronin, CEO, President & Director of Patriot One.
This is right after the Counter Terrorism Conference event beginning tomorrow and the World Game Protection Conference next week.
Chris Mitchell:
Hi
Morris LeBlanc:
It was great to sit down with Martin and Jeff and go through an update!
To your questions:
#1 With their currently supply chain they can produce up to 2,000 units per month if they give a six week lead time. The company that builds the hardware is called Copper Mountain Technologies - they are based in the US. This will change when they announce their Tier one partnerships.
#2 The are looking at more than one Tier 1 company. Jeff said PAT has over 9,000 leads with resellers and end-users right now. They are in discussions and advanced discussions with the largest integrators in the security space.
You will probably see some of those relationships coming out over the next six months as we roll out. This is not a plug-and-play. It does take integration, so by no means is PAT going to have a 1,000 person team to install all this so its really teaming up the Siemens, the Honeywells, the Tycos etc. They all have a very strong interest in us as it is disruptive and right now we think we have a 2-3 year head start.
There is nothing with this sort of small profile covert technology out there in this price range. With the demand in Vegas we could have sold 3,000 units in the past week alone, so it just a matter of rolling it out properly and being able to meet the demand without giving too high of an expectation.
#3 We continue to fund the research at McMaster, UBC, as well as in the UK. We are working on wearable and vehicle mounted device. They refereed this as pulse radar.
Chris Mitchell:
Their biggest challenge right now before roll out is to get the algorithm optimized to their standards. It is difficult to shortcut when training the algorithms. It is a time consuming and resource-consumptive process because there are a lot of variables in the real world. It is quite an intense exercise for the engineers to train the algorithms as to what it is they are seeing. For example, an air conditioning unit gives off a signal that needs to be discounted or a signal for a temperature change etc. There is no real shortcut to it - we need it to be robust."
He mentioned that they are also using IBM's Watson technology to help with our algorithm development. They will have an independent third party test the system and if it passes to their liking then they will be comfortable with the mass roll out.
Chris Mitchell:
1) According to Cronin, the installation at Westgate (hotel in Las Vegas) is going very well.
2) Preorders are capped right now at around 500 units. We don't want to have a big gap between orders and then the ability to deliver. So these are from early stage adopters and distributers and they understand at the stage we are at, but want to be in the first wave of deployment. We have a number of markets lined up - UK, Australia, New Zealand, Latin America, Caribbean, Europe and the Middle East.
Specializes in the development and marketing of products for the fitness and wellness markets. The company is founded based on creating high-quality, sustainable, products for health-conscious consumers. Elev8 Hemp LLC is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the development and marketing of hemp-based food, beverage, and health care products including hemp coffee, hemp water, and hemp-based skin care products. 02 Breathe is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on their oxygen bar while bringing in an array of CBD products. O2 Breathe carries CBD tinctures, CBD vape, CBD lotions and message products. (ALL HEMP) 02 Breathe is currently looking to offer CBD at their oxygen bar.
Hemp water ... yummmm
Hemp coffee ... where do I signup?
Sorry. I am only interested in "whole plant" CBD's.
Gotta give it to VATE. 2 big days in a row. Sector is blowing up. I think they're all gonna blow again. Pick you favorites and stand by for 200-400-1000% It's not easy to hold for 1000% lol
Namaste Announces LOI with Inolife R&D to Conduct a Research Study to Evaluate Needle-Free Injection Technologies for Medical Cannabis
March 12, 2018 by Namaste Technologies
FOR IMMEDIATE RELEASE – March 12th, 2018
Vancouver, British Columbia, Canada – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE: N) (FRA: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that it has signed a non-binding LOI with Inolife R&D Inc. (“Inolife”), whereby Namaste and Inolife will negotiate the terms of a definitive agreement (the “Agreement”) to initiate a research study to evaluate applications for Inolife’s proprietary needle-free injectors in the medical cannabis industry.
Under the terms of the LOI and proposed Agreement, Namaste will hold exclusive rights to research and distribute Inolife’s needle-free injection technologies for applications in the cannabis industry.
Namaste will also participate in Inolife’s anticipated private placement by acquiring up to 10% of the shares issued under the offering. Inolife will also provide Namaste with the right to acquire up to an additional 10% of the shares issued under the offering at the same price.
Additionally, Namaste will purchase up to 10% of the shares issued in connection with Inolife’s go-public transaction for approximately $250,000. Namaste believes that Inolife’s needle-free technologies could revolutionize dosage and administration of cannabis for medical purposes.
The LOI and proposed Agreement represent a strategic initiative for Namaste’s continued effort to offer innovative products to the medical cannabis market. Namaste believes that Inolife’s technology provides the most accurate and efficient method for dosing with medical cannabis.
Namaste expects to work within Health Canada’s current and future cannabis regulations when proceeding towards commercialization of pre-filled needle-free syringes. Namaste expects to commercialize the pre-filled needle-free syringes through its wholly owned subsidiary and late-stage applicant under Access to Cannabis for Medical Purposes Regulations (“ACMPR”), Cannmart Inc.
The Company also expects to engage with Canadian ACMPR medical cannabis producers to co-brand medical cannabis oil, to be sold and used for applications with Inolife’s technology.
Key Terms of the LOI
Namaste will initiate a research study to determine the viability to use Inolife’s needle-free injectors for medical cannabis.
Namaste will bear all costs for research and development.
Namaste will participate for up to 10% of Inolife’s anticipated private placement and go-public transaction.
Namaste will have exclusive rights to distribute Inolife’s products for the purposes of use with medical cannabis.
Both parties agree to a 30-day period from the execution date of the LOI to negotiate terms of a definitive agreement and establish a protocol to proceed with a research study.
Management Commentary
Michael Wright, President and CEO of Inolife comments, “We’re very excited about the proposed partnership with Namaste. We feel that Namaste is best positioned to deliver on our strategic plan to become an innovator of delivery systems for the medical cannabis industry.
We’re pleased to be the first company, in partnership with Namaste, to explore needle-free device technology in the context of medical cannabis delivery.”
Sean Dollinger, President and CEO of Namaste comments, “We are very pleased to announce this LOI and our expectation of providing research and development of this innovative technology for applications with medical cannabis.
We believe that Inolife’s technology could provide the most efficient and accurate method for dosing with medical cannabis. We see a massive opportunity to revolutionize the industry by bringing this exciting technology to the medical cannabis market. We’re delighted to see that industry-leading companies like Inolife are recognizing Namaste for its value in its database, platform and brand.”
About Inolife R&D Inc.
Inolife R&D Inc. is an emerging specialty medical device company focused on developing and commercializing self-administered medical products using novel drug delivery technologies. The company was founded to take advantage of novel techniques of liquid jet and ballistics-based epidermal drug injection that we believe will improve a patient’s quality of life by making medicines easier to self-administer, work better, and remove the anxiety and inconvenience associated with hypodermic needle injections.
About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world.
Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile.
Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market.
Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.
Namaste Announces LOI with Inolife R&D to Conduct a Research Study to Evaluate Needle-Free Injection Technologies for Medical Cannabis
March 12, 2018 by Namaste Technologies
FOR IMMEDIATE RELEASE – March 12th, 2018
Vancouver, British Columbia, Canada – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE: N) (FRA: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that it has signed a non-binding LOI with Inolife R&D Inc. (“Inolife”), whereby Namaste and Inolife will negotiate the terms of a definitive agreement (the “Agreement”) to initiate a research study to evaluate applications for Inolife’s proprietary needle-free injectors in the medical cannabis industry.
Under the terms of the LOI and proposed Agreement, Namaste will hold exclusive rights to research and distribute Inolife’s needle-free injection technologies for applications in the cannabis industry.
Namaste will also participate in Inolife’s anticipated private placement by acquiring up to 10% of the shares issued under the offering. Inolife will also provide Namaste with the right to acquire up to an additional 10% of the shares issued under the offering at the same price.
Additionally, Namaste will purchase up to 10% of the shares issued in connection with Inolife’s go-public transaction for approximately $250,000. Namaste believes that Inolife’s needle-free technologies could revolutionize dosage and administration of cannabis for medical purposes.
The LOI and proposed Agreement represent a strategic initiative for Namaste’s continued effort to offer innovative products to the medical cannabis market. Namaste believes that Inolife’s technology provides the most accurate and efficient method for dosing with medical cannabis.
Namaste expects to work within Health Canada’s current and future cannabis regulations when proceeding towards commercialization of pre-filled needle-free syringes. Namaste expects to commercialize the pre-filled needle-free syringes through its wholly owned subsidiary and late-stage applicant under Access to Cannabis for Medical Purposes Regulations (“ACMPR”), Cannmart Inc.
The Company also expects to engage with Canadian ACMPR medical cannabis producers to co-brand medical cannabis oil, to be sold and used for applications with Inolife’s technology.
Key Terms of the LOI
Namaste will initiate a research study to determine the viability to use Inolife’s needle-free injectors for medical cannabis.
Namaste will bear all costs for research and development.
Namaste will participate for up to 10% of Inolife’s anticipated private placement and go-public transaction.
Namaste will have exclusive rights to distribute Inolife’s products for the purposes of use with medical cannabis.
Both parties agree to a 30-day period from the execution date of the LOI to negotiate terms of a definitive agreement and establish a protocol to proceed with a research study.
Management Commentary
Michael Wright, President and CEO of Inolife comments, “We’re very excited about the proposed partnership with Namaste. We feel that Namaste is best positioned to deliver on our strategic plan to become an innovator of delivery systems for the medical cannabis industry.
We’re pleased to be the first company, in partnership with Namaste, to explore needle-free device technology in the context of medical cannabis delivery.”
Sean Dollinger, President and CEO of Namaste comments, “We are very pleased to announce this LOI and our expectation of providing research and development of this innovative technology for applications with medical cannabis.
We believe that Inolife’s technology could provide the most efficient and accurate method for dosing with medical cannabis. We see a massive opportunity to revolutionize the industry by bringing this exciting technology to the medical cannabis market. We’re delighted to see that industry-leading companies like Inolife are recognizing Namaste for its value in its database, platform and brand.”
About Inolife R&D Inc.
Inolife R&D Inc. is an emerging specialty medical device company focused on developing and commercializing self-administered medical products using novel drug delivery technologies. The company was founded to take advantage of novel techniques of liquid jet and ballistics-based epidermal drug injection that we believe will improve a patient’s quality of life by making medicines easier to self-administer, work better, and remove the anxiety and inconvenience associated with hypodermic needle injections.
About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world.
Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile.
Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market.
Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.
I was using a calculator and came up with approximately 411,000,000 shares fully diluted.
Sound about right?
Any concern over management shakeup? What do you think about current management team?
What do you think about MJ product supply and demand Canada next 5 years?
One thing that strikes me. Taking medical marijuana use out of the equation and leaving only recreational MJ. Isn't that A LOT of pot to be smoked in the country annually? Is everyone in Canada going to be stoned all of the time? Is there really a demand for recreational use that would support the tons and tons of dried product coming online?
News 
Market Data 
Discover 
